PlainRecalls
FDA Drug Moderate Class II Ongoing

bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226

Reported: September 24, 2025 Initiated: August 29, 2025 #D-0646-2025

Product Description

bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226

Reason for Recall

Lack of Assurance of Sterility

Details

Units Affected
109,320 syringes
Distribution
USA nationwide.
Location
Wichita, KS

Frequently Asked Questions

What product was recalled?
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226. Recalled by Fagron Compounding Services. Units affected: 109,320 syringes.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on September 24, 2025. Severity: Moderate. Recall number: D-0646-2025.